{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:13:12Z","timestamp":1791576792888,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00277-024-05757-1","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T06:18:58Z","timestamp":1713421138000},"page":"2133-2144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial"],"prefix":"10.1007","volume":"103","author":[{"given":"Aishwarya","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen C","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulkit","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh P","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritin","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Vijayvergiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8552-2796","authenticated-orcid":false,"given":"Amol N","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"5757_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ihj.2022.03.008","volume":"74","author":"A Anand","year":"2022","unstructured":"Anand A, Kumar R, Gupta A et al (2022) Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: a cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting. Indian Heart J 74:245\u2013248. https:\/\/doi.org\/10.1016\/j.ihj.2022.03.008","journal-title":"Indian Heart J"},{"key":"5757_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000519462","volume":"25","author":"N Kaur","year":"2022","unstructured":"Kaur N, Pandey A, Shafiq N et al (2022) Genetic and nongenetic determinants of variable warfarin dose requirements: a Report from North India. Public Health Genomics 25:52\u201360. https:\/\/doi.org\/10.1159\/000519462","journal-title":"Public Health Genomics"},{"key":"5757_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/00185787211070182","volume":"57","author":"D George","year":"2022","unstructured":"George D, Wong CA, Thanimalai S, Tan HS (2022) Severity and hospitalization cost related to warfarin-related adverse events in a tertiary Malaysian hospital. Hosp Pharm 57:633\u2013638. https:\/\/doi.org\/10.1177\/00185787211070182","journal-title":"Hosp Pharm"},{"key":"5757_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1515\/dmpt-2022-0189","volume":"38","author":"A Anand","year":"2023","unstructured":"Anand A, Kumar R, Sharma S et al (2023) Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population. Drug Metab Pers Ther 38:273\u2013279. https:\/\/doi.org\/10.1515\/dmpt-2022-0189","journal-title":"Drug Metab Pers Ther"},{"key":"5757_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jpm7040020","volume":"7","author":"TJ Wigle","year":"2017","unstructured":"Wigle TJ, Jansen LE, Teft WA, Kim RB (2017) Pharmacogenomics guided-personalization of warfarin and tamoxifen. J Pers Med 7:20. https:\/\/doi.org\/10.3390\/jpm7040020","journal-title":"J Pers Med"},{"key":"5757_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/ph16111568","volume":"16","author":"J Jian","year":"2023","unstructured":"Jian J, He D, Gao S et al (2023) Pharmacokinetics in Pharmacometabolomics: towards personalized medication. Pharm Basel Switz 16:1568. https:\/\/doi.org\/10.3390\/ph16111568","journal-title":"Pharm Basel Switz"},{"issue":"11","key":"5757_CR7","doi-asserted-by":"publisher","first-page":"e27808","DOI":"10.1371\/journal.pone.0027808","volume":"6","author":"IY Gong","year":"2011","unstructured":"Gong IY, Schwarz UI, Crown N et al (2011) Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation. PLoS ONE 6(11):e27808. https:\/\/doi.org\/10.1371\/journal.pone.0027808","journal-title":"PLoS ONE"},{"key":"5757_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","volume":"102","author":"JA Johnson","year":"2017","unstructured":"Johnson JA, Caudle KE, Gong L et al (2017) Clinical pharmacogenetics implementation Consortium (CPIC) Guideline for Pharmacogenetics-guided warfarin dosing: 2017 update. Clin Pharmacol Ther 102:397\u2013404. https:\/\/doi.org\/10.1002\/cpt.668","journal-title":"Clin Pharmacol Ther"},{"key":"5757_CR9","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1161\/CIRCULATIONAHA.107.737312","volume":"116","author":"JL Anderson","year":"2007","unstructured":"Anderson JL, Horne BD, Stevens SM et al (2007) Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. Circulation 116:2563\u20132570. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.737312","journal-title":"Circulation"},{"key":"5757_CR10","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.111.070920","volume":"125","author":"JL Anderson","year":"2012","unstructured":"Anderson JL, Horne BD, Stevens SM et al (2012) A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation 125:1997\u20132005. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.070920","journal-title":"Circulation"},{"key":"5757_CR11","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","volume":"369","author":"SE Kimmel","year":"2013","unstructured":"Kimmel SE, French B, Kasner SE et al (2013) A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 369:2283\u20132293. https:\/\/doi.org\/10.1056\/NEJMoa1310669","journal-title":"N Engl J Med"},{"key":"5757_CR12","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","volume":"369","author":"M Pirmohamed","year":"2013","unstructured":"Pirmohamed M, Burnside G, Eriksson N et al (2013) A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 369:2294\u20132303. https:\/\/doi.org\/10.1056\/. https:\/\/www.zotero.org\/google-docs\/?GDnttIMoa1311386","journal-title":"N Engl J Med"},{"key":"5757_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.09.002","volume":"22","author":"BK Ray","year":"2013","unstructured":"Ray BK, Hazra A, Ghosal M et al (2013) Early and delayed fatality of stroke in Kolkata, India: results from a 7-year longitudinal population-based study. J Stroke Cerebrovasc Dis off J Natl Stroke Assoc 22:281\u2013289. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2011.09.002","journal-title":"J Stroke Cerebrovasc Dis off J Natl Stroke Assoc"},{"key":"5757_CR14","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.cir.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946\u2013952. https:\/\/doi.org\/10.1161\/01.cir.98.10.946","journal-title":"Circulation"},{"key":"5757_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/tpj.2016.41","volume":"16","author":"TI Verhoef","year":"2016","unstructured":"Verhoef TI, Redekop WK, Langenskiold S et al (2016) Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. Pharmacogenomics J 16:478\u2013484. https:\/\/doi.org\/10.1038\/tpj.2016.41","journal-title":"Pharmacogenomics J"},{"key":"5757_CR16","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jval.2021.11.1370","volume":"25","author":"G Jyani","year":"2022","unstructured":"Jyani G, Sharma A, Prinja S et al (2022) Development of an EQ-5D value set for India using an Extended Design (DEVINE) study: the Indian 5-Level version EQ-5D Value Set. Value Health J Int Soc Pharmacoeconomics Outcomes Res 25:1218\u20131226. https:\/\/doi.org\/10.1016\/j.jval.2021.11.1370","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"11","key":"5757_CR17","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1007\/s00277-023-05342-y","volume":"102","author":"NC Hegde","year":"2023","unstructured":"Hegde NC, Kumar A, Kaundal S et al (2023) Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia. Ann Hematol 102(11):3125\u20133132. https:\/\/doi.org\/10.1007\/s00277-023-05342-y Epub 2023 Jul 13. PMID: 37439892","journal-title":"Ann Hematol"},{"issue":"10","key":"5757_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883\u2013891. https:\/\/doi.org\/10.1056\/NEJMoa1009638Epub 2011 Aug 10. PMID: 21830957","journal-title":"N Engl J Med"},{"key":"5757_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12916-018-1093-8","volume":"16","author":"NL Syn","year":"2018","unstructured":"Syn NL, Wong AL-A, Lee S-C et al (2018) Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial. BMC Med 16:104. https:\/\/doi.org\/10.1186\/s12916-018-1093-8","journal-title":"BMC Med"},{"key":"5757_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2217\/pgs.09.125","volume":"10","author":"RMF van Schie","year":"2009","unstructured":"van Schie RMF, Wadelius MIA, Kamali F et al (2009) Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics 10:1687\u20131695. https:\/\/doi.org\/10.2217\/pgs.09.125","journal-title":"Pharmacogenomics"},{"key":"5757_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.7150\/ijms.4637","volume":"9","author":"M Wang","year":"2012","unstructured":"Wang M, Lang X, Cui S et al (2012) Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: a randomized and controlled trial. Int J Med Sci 9:472\u2013479. https:\/\/doi.org\/10.7150\/ijms.4637","journal-title":"Int J Med Sci"},{"key":"5757_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2217\/pgs.14.167","volume":"16","author":"C Mitropoulou","year":"2015","unstructured":"Mitropoulou C, Fragoulakis V, Bozina N et al (2015) Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke. Pharmacogenomics 16:137\u2013148. https:\/\/doi.org\/10.2217\/pgs.14.167","journal-title":"Pharmacogenomics"},{"key":"5757_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCOUTCOMES.108.808592","volume":"2","author":"AR Patrick","year":"2009","unstructured":"Patrick AR, Avorn J, Choudhry NK (2009) Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2:429\u2013436. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.108.808592","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05757-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:07:51Z","timestamp":1715566071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05757-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5757"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05757-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"26 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}